Wendell Wierenga

1.4k total citations
53 papers, 1.1k citations indexed

About

Wendell Wierenga is a scholar working on Organic Chemistry, Molecular Biology and Hematology. According to data from OpenAlex, Wendell Wierenga has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Organic Chemistry, 19 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Wendell Wierenga's work include Synthesis and Biological Evaluation (13 papers), Synthesis and Reactions of Organic Compounds (11 papers) and Synthesis and biological activity (10 papers). Wendell Wierenga is often cited by papers focused on Synthesis and Biological Evaluation (13 papers), Synthesis and Reactions of Organic Compounds (11 papers) and Synthesis and biological activity (10 papers). Wendell Wierenga collaborates with scholars based in United States. Wendell Wierenga's co-authors include Harvey I. Skulnick, Robert C. Kelly, Martha A. Warpehoski, Robert J. Smith, William C. Krueger, Michael P. Doyle, J. Patrick McGovren, Susan S. Iden, Dale A. Stringfellow and Harold E. Renis and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Biochemistry.

In The Last Decade

Wendell Wierenga

50 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendell Wierenga United States 20 519 487 103 98 98 53 1.1k
Harold R. Almond United States 18 590 1.1× 472 1.0× 72 0.7× 150 1.5× 68 0.7× 32 1.2k
Mario Guarneri Italy 17 517 1.0× 377 0.8× 36 0.3× 56 0.6× 110 1.1× 83 1.1k
Walter H.J. Ward United Kingdom 18 985 1.9× 264 0.5× 72 0.7× 87 0.9× 298 3.0× 33 1.6k
Joseph I. DeGraw United States 19 560 1.1× 583 1.2× 98 1.0× 61 0.6× 211 2.2× 108 1.4k
Keiko Kuroda Japan 18 254 0.5× 268 0.6× 97 0.9× 39 0.4× 62 0.6× 63 1.0k
Stephen Brand United Kingdom 18 476 0.9× 406 0.8× 105 1.0× 42 0.4× 104 1.1× 26 999
Mark A. Ashwell United Kingdom 18 556 1.1× 423 0.9× 56 0.5× 68 0.7× 206 2.1× 39 1.2k
Roderick J. Sorenson United States 19 647 1.2× 632 1.3× 33 0.3× 156 1.6× 103 1.1× 35 1.4k
Fredrik Lehmann Sweden 17 575 1.1× 278 0.6× 108 1.0× 68 0.7× 210 2.1× 59 1.1k
Margarete Neu United Kingdom 19 531 1.0× 221 0.5× 74 0.7× 106 1.1× 125 1.3× 28 1.0k

Countries citing papers authored by Wendell Wierenga

Since Specialization
Citations

This map shows the geographic impact of Wendell Wierenga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendell Wierenga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendell Wierenga more than expected).

Fields of papers citing papers by Wendell Wierenga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendell Wierenga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendell Wierenga. The network helps show where Wendell Wierenga may publish in the future.

Co-authorship network of co-authors of Wendell Wierenga

This figure shows the co-authorship network connecting the top 25 collaborators of Wendell Wierenga. A scholar is included among the top collaborators of Wendell Wierenga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendell Wierenga. Wendell Wierenga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gunawardane, Ruwanthi N., Daniel Brigham, Jill M. Ricono, et al.. (2010). Abstract 3619: Inhibition of FLT3 autophosphorylation and downstream signaling both in vitro and in vivo by AC220, a second generation potent and selective FLT3 inhibitor. Cancer Research. 70(8_Supplement). 3619–3619. 1 indexed citations
3.
Cortes, Jörge E., James M. Foran, Darejan Ghirdaladze, et al.. (2009). AC220, a Potent, Selective, Second Generation FLT3 Receptor Tyrosine Kinase (RTK) Inhibitor, in a First-in-Human (FIH) Phase 1 AML Study.. Blood. 114(22). 636–636. 54 indexed citations
4.
Wierenga, Wendell. (1993). Overview on the Chemistry and Immunomodulating Properties of Novel Pyrimidinones. Annals of the New York Academy of Sciences. 685(1). 296–300. 2 indexed citations
5.
6.
Scahill, Terrence A., Randy Jensen, David H. Swenson, et al.. (1990). An NMR study of the covalent and noncovalent interactions of CC-1065 and DNA. Biochemistry. 29(11). 2852–2860. 39 indexed citations
7.
Wierenga, Wendell & David J. Wustrow. (1989). Synthesis of a 3-Acetoxy-6-phenylpyrone and Its Conversion to a Pyrido[1,4]benzodiazepine. Heterocycles. 29(9). 1721–1721. 1 indexed citations
8.
Warpehoski, Martha A., Ilse Gebhard, Robert C. Kelly, et al.. (1988). Stereoelectronic factors influencing the biological activity and DNA interaction of synthetic antitumor agents modeled on CC-1065. Journal of Medicinal Chemistry. 31(3). 590–603. 117 indexed citations
9.
Li, Lianhe, et al.. (1987). Antitumor activity of pyrimidinones, a class of small-molecule biological response modifiers.. PubMed. 6(1). 44–55. 8 indexed citations
10.
Skulnick, Harvey I., James H. Ludens, Michael G. Wendling, et al.. (1986). Pyrimidinones. 3. N-Substituted 6-phenylpyrimidinones and pyrimidinediones with diuretic/hypotensive and antiinflammatory activity. Journal of Medicinal Chemistry. 29(8). 1499–1504. 33 indexed citations
11.
Chuang, Christy, et al.. (1986). Chemoprevention of 7,12-dimethylbenz(alpha)anthracene (DMBA) induced rat mammary tumors by 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP).. PubMed. 5(2). 112–6. 4 indexed citations
12.
Wierenga, Wendell. (1985). Antiviral and other bioactivities of pyrimidinones. Pharmacology & Therapeutics. 30(1). 67–89. 54 indexed citations
13.
Skulnick, Harvey I., et al.. (1985). Pyrimidinones. 1. 2-Amino-5-halo-6-aryl-4(3H)-pyrimidinones. Interferon-inducing antiviral agents. Journal of Medicinal Chemistry. 28(12). 1864–1869. 41 indexed citations
14.
Wierenga, Wendell, Barbara R. Evans, & Gary E. Zurenko. (1984). Benzisoxazolones: antimicrobial and antileukemic activity. Journal of Medicinal Chemistry. 27(9). 1212–1215. 29 indexed citations
15.
Wierenga, Wendell. (1984). ABPP. Drugs of the Future. 9(8). 567–567. 2 indexed citations
16.
Wierenga, Wendell. (1981). Synthesis of the left-hand segment of the antitumor agent CC-1065. Journal of the American Chemical Society. 103(18). 5621–5623. 41 indexed citations
17.
Wierenga, Wendell, et al.. (1980). 5-Substituted 2-amino-6-phenyl-4(3H)-pyrimidinones. Antiviral- and interferon-inducing agents. Journal of Medicinal Chemistry. 23(3). 237–239. 41 indexed citations
18.
Kelly, Robert C., et al.. (1979). Total synthesis of .alpha.-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125), an antitumor antibiotic. Journal of the American Chemical Society. 101(4). 1054–1056. 37 indexed citations
19.
Doyle, Michael P. & Wendell Wierenga. (1972). Reactions of the nitrosonium ion. III. Reaction of alkyl azides with nitrosonium compounds. Effect of solvent, quenching agent, and nitrosonium compound. Journal of the American Chemical Society. 94(11). 3901–3906. 1 indexed citations
20.
Tamelen, Eugene E. Van, et al.. (1972). Biogenetic-type total synthesis. .delta.-Amyrin, .beta.-amyrin, and germanicol. Journal of the American Chemical Society. 94(23). 8229–8231. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harold R. Almond Breakdown of academic impact, for papers by Mario Guarneri Breakdown of academic impact, for papers by Walter H.J. Ward Breakdown of academic impact, for papers by Joseph I. DeGraw Breakdown of academic impact, for papers by Keiko Kuroda Breakdown of academic impact, for papers by Stephen Brand Breakdown of academic impact, for papers by Mark A. Ashwell Breakdown of academic impact, for papers by Roderick J. Sorenson Breakdown of academic impact, for papers by Fredrik Lehmann Breakdown of academic impact, for papers by Margarete Neu
Rankless by CCL
2026